Atlas FDA

HER OPTION (TM) UTERINE CRYOBLATION THERAPY SYSTEM

FDA premarket approval P000032 · decided 2001-04-20

Approval details

PMA number
P000032
Trade name
HER OPTION (TM) UTERINE CRYOBLATION THERAPY SYSTEM
Generic name
Device, thermal ablation, endometrial
Applicant
CooperSurgical, Inc.
Date received
2000-07-27
Decision date
2001-04-20
Days to decision
267 days
Decision code
APWD
Product code
MNB
Advisory committee
Obstetrics/Gynecology
Expedited review
No
Location
Trumbull, CT
Statement
APPROVAL FOR THE HEROPTION(TM) UTERINE CRYOBLATION THERAPY(TM) SYSTEM. THE DEVICE IS A CLOSED-CYCLE CRYOSURGICAL DEVICE INTENDED TO ABLATE THE ENDOMETRIAL LINING OF THE UTERUS IN PRE-MENOPAUSAL WOMEN WITH MENORRHAGIA (EXCESSIVE BLEEDING) DUE TO BENIGN CAUSES FOR WHOM CHILDBEARING IS COMPLETE.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Fetal Pillow (K243799)CooperSurgical, Inc.2025-08-29
CooperSurgical Milex® Pessaries (K250438)CooperSurgical, Inc.2025-04-11
ALLY II Uterine Positioning System™ (UPS) (K223064)CooperSurgical, Inc.2022-10-28
Advincula Delineator Uterine Manipulator (K201086)CooperSurgical, Inc.2020-05-21
Endosee System (K200038)CooperSurgical, Inc.2020-02-05
G210 InviCell Plus with SignipHy pH monitoring (K191020)CooperSurgical, Inc.2020-01-14
Wallace Dual Lumen Oocyte Recovery System (K191291)CooperSurgical, Inc.2019-06-12
Endosee System (K190639)CooperSurgical, Inc.2019-05-15